European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke
Leitlinien der European Stroke Organisation (ESO) zur Diagnose und Behandlung eines offenen Foramen ovale (PFO) nach Schlaganfall
European Stroke Journal · 01.12.2024 · 9 (4) · 800-834
DOI: 10.1177/23969873241247978 ↗Auf einen Blick
Die ESO gibt Empfehlungen zur Diagnostik, Behandlung und Langzeitbetreuung von Patient:innen mit ischämischem Schlaganfall und PFO. Empfohlen wird bei ausgewählten 18- bis 60-Jährigen der PFO-Verschluss plus Thrombozytenhemmung.
Fragestellung
Welche Empfehlungen gelten für Diagnostik, Behandlung und Langzeitmanagement bei ischämischem Schlaganfall und PFO?
Methode
Leitlinie nach GRADE und ESO-Verfahren; Begutachtung durch unabhängige Expert:innen sowie ESO Guideline Board und Executive Committee.
Ergebnisse
Hohe Evidenz für PFO-Verschluss plus antiplättchenbasierte Therapie bei ausgewählten 18- bis 60-Jährigen ohne andere erkennbare Schlaganfallursache. PASCAL kann zur Auswahl genutzt werden; bei großem Shunt und Vorhofseptumaneurysma profitieren Patient:innen am meisten.
Einschränkungen
Keine evidenzbasierte Empfehlung zum PFO-Verschluss bei >60-Jährigen und <18-Jährigen. Unsicherheit zu Nutzen/Risiken einer langfristigen Rhythmusüberwachung nach Verschluss.
Schlussfolgerung der Autor:innen
Bei ausgewählten Patient:innen mit PFO-assoziiertem Schlaganfall wird PFO-Verschluss plus antiplättchenbasierte Therapie empfohlen. Für andere Altersgruppen und einige Langzeitfragen bleibt die Evidenz unzureichend.
Kernaussagen
- PFO-Verschluss plus antiplättchenbasierte Therapie bei ausgewählten 18- bis 60-Jährigen empfohlen
- PASCAL hilft bei der Auswahl geeigneter Kandidat:innen
- Langfristige Antikoagulation wird bei PFO-assoziiertem Schlaganfall meist nicht empfohlen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Leitlinie in der Zeitschrift European Stroke Journal, online erschienen am 01.12.2024. Verfasst von Valeria Caso und 11 weiteren Autor:innen. Beteiligte Einrichtung: Stroke Unit, Santa Maria della Misericordia Hospital-University of Perugia, Santa Maria della Misericordia Hospital -University of Perugia, Perugia, …. Hauptthemen laut MEDLINE: Foramen Ovale, Patent. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Stroke Organisation.
Themen: Schlaganfall
Abstract (Originalsprache)
Patent foramen ovale (PFO) is frequently identified in young patients with cryptogenic ischaemic stroke. Potential stroke mechanisms include paradoxical embolism from a venous clot which traverses the PFO, in situ clot formation within the PFO, and atrial arrhythmias due to electrical signalling disruption. The purpose of this guideline is to provide recommendations for diagnosing, treating, and long-term managing patients with ischaemic stroke and PFO. Conversely, Transient Ischaemic Attack (TIA) was not considered an index event in this context because only one RCT involved TIA patients. However, this subgroup analysis showed no significant differences between TIA and stroke outcomes. The working group identified questions and outcomes, graded evidence, and developed recommendations following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach and the European Stroke Organisation (ESO) standard operating procedure for guideline development. This document underwent peer-review by independent experts and members of the ESO Guideline Board and Executive Committee. The working group acknowledges the current evidentiary gap in delineating an unequivocal diagnostic algorithm for the detection of PFO. Although transoesophageal echocardiography is conventionally held as the most accurate diagnostic tool for PFO identification, its status as the ‘gold standard’ remains unsubstantiated by rigorously validated evidence. We found high-quality evidence to recommend PFO closure plus antiplatelet therapy in selected patients aged 18–60 years in whom no other evident cause of stroke is found but a PFO (i.e. PFO-associated stroke). The PASCAL classification system can be used to select such candidates for PFO closure. Patients with both a large right-to-left shunt and an atrial septal aneurysm benefit most from PFO closure. There is insufficient evidence to make an evidence-based recommendation on PFO closure in patients older than 60 and younger than 18 years. We found low quality evidence to suggest against PFO closure in patients with unlikely PFO-related stroke according to the PASCAL classification, except in specific scenarios (Expert Consensus). We suggest against long-term anticoagulation in patients with PFO-associated stroke unless anticoagulation is indicated for other medical reasons. Regarding the long-term AF monitoring after PFO closure, the working group concluded that there remains significant uncertainty regarding the risks and benefits associated with the use of long-term cardiac monitoring, such as implantable loop recorders. This document provides additional guidance, in the form of evidence-based recommendations or expert consensus statements, on diagnostic methods for PFO detection, and medical management after PFO closure. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stroke Unit, Santa Maria della Misericordia Hospital-University of Perugia, Santa Maria della Misericordia Hospital -University of Perugia, Perugia, Italy.
- Department of Neurology, GHU Paris Psychiatrie et Neurosciences, Université de Paris, INSERM U1266, FHU NeuroVasc, Paris, France.
- Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
- Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
- Stroke Division, Department of Medicine for Older People, Whiston Hospital, Mersey and West Lancashire Teaching Hospitals NHS Trust, Prescot, UK.
- Department of Neurology, Centro Hospitalar Universitário de São João Faculty of Medicine University of Porto, Porto, Portugal.
ORCID-Profile: Valeria Caso, Guillaume Turc, Azmil H Abdul-Rahim, Salman Hussain, Heinrich Mattle, Eleni Korompoki, Silke Walter
Förderung
- European Stroke Organisation
Zitieren
APA
Caso, V., Turc, G., Abdul-Rahim, A. H., Castro, P., Hussain, S., Lal, A., Mattle, H., Korompoki, E., Søndergaard, L., Toni, D., Walter, S., & Pristipino, C. (2024). European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke. European Stroke Journal, 9(4), 800-834. https://doi.org/10.1177/23969873241247978
Vancouver
Caso V, Turc G, Abdul-Rahim AH, Castro P, Hussain S, Lal A, et al. European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke. European Stroke Journal. 2024;9(4):800-834. doi:10.1177/23969873241247978
BibTeX
@article{Caso2024,
author = {Caso, Valeria and Turc, Guillaume and Abdul-Rahim, Azmil H and Castro, Pedro and Hussain, Salman and Lal, Avtar and Mattle, Heinrich and Korompoki, Eleni and Søndergaard, Lars and Toni, Danilo and Walter, Silke and Pristipino, Christian},
title = {European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke},
journal = {European Stroke Journal},
year = {2024},
volume = {9},
number = {4},
pages = {800--834},
doi = {10.1177/23969873241247978}
}
EUVIMED